LGT Group Foundation’s CVS Health CVS Stock Holding History

LGT Group Foundation’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$321K	Sell	4,468 -872	-16%	-$67.2K	﹤0.01%	248
2025 Q4	$426K	Hold	5,340	–	–	﹤0.01%	234
2025 Q3	$410K	Sell	5,340 -3,030	-36%	-$208K	﹤0.01%	235
2025 Q2	$577K	Sell	8,370 -325	-4%	-$21.3K	0.01%	225
2025 Q1	$589K	Sell	8,695 -35,227	-80%	-$2.11M	0.01%	220
2024 Q4	$1.97M	Sell	43,922 -14,750	-25%	-$827K	0.03%	170
2024 Q3	$3.65M	Buy	58,672 +38,125	+186%	+$2.22M	0.06%	157
2024 Q2	$1.21M	Sell	20,547 -3,656	-15%	-$229K	0.02%	196
2024 Q1	$1.93M	Buy	24,203 +736	+3%	+$56.2K	0.05%	170
2023 Q4	$1.85M	Buy	23,467 +516	+2%	+$36.7K	0.04%	182
2023 Q3	$1.6M	Buy	22,951 +971	+4%	+$68.8K	0.04%	191
2023 Q2	$1.52M	Sell	21,980 -881	-4%	-$62.7K	0.04%	207
2023 Q1	$1.7M	Buy	22,861 +11,997	+110%	+$1.01M	0.05%	206
2022 Q4	$1.01M	Sell	10,864 -298	-3%	-$28.8K	0.03%	220
2022 Q3	$1.06M	Sell	11,162 -26,273	-70%	-$2.6M	0.04%	193
2022 Q2	$3.47M	Buy	37,435 +825	+2%	+$80.5K	0.11%	151
2022 Q1	$3.7M	Buy	36,610 +11,580	+46%	+$1.22M	0.09%	163
2021 Q4	$2.58M	Buy	+25,030	New	+$2.31M	0.07%	171

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LGT Group Foundation's CVS Position: Q1 2026 in Review

LGT Group Foundation reduced its CVS Health (CVS) stake by 16% in Q1 2026, selling an estimated $67.2K and leaving 4,468 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #248.

LGT Group Foundation first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.7M in Q1 2022. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

LGT Group Foundation held 4,468 shares of CVS Health worth $321K as of Q1 2026.
LGT Group Foundation sold 872 CVS Health shares in Q1 2026, an estimated $67.2K.
CVS Health made up ﹤0.01% of LGT Group Foundation's portfolio in Q1 2026, its #248 holding.
LGT Group Foundation first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
LGT Group Foundation's CVS Health position peaked at $3.7M in Q1 2022.
1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on LGT Group Foundation's 13F filing for Q1 2026, filed 28 Apr 2026.